FIELD: chemistry.
SUBSTANCE: invention relates to a N-(2-oxo-2-propoxyethyl)-β-phenyl-D- phenylalanyl-N-[(1-amino-6-isoquinolinyl)-methyl]-L-proline amide compound or pharmaceutically acceptable salt thereof, a pharmaceutical composition containing said compound, as well as use of the compound to produce a medicinal agent for treating or preventing thrombin-mediated diseases. The invention also relates to a N-(carboxymethyl)-β-phenyl-D-phenylalanyl-N-[(1-amino-6-isoquinolinyl)methyl]-L-proline amide compound of pharmaceutically acceptable salt thereof.
EFFECT: obtaining novel compounds possessing useful biological properties.
5 cl, 2 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
| BICYCLIC INHIBITORS | 2014 |
|
RU2672582C2 |
| NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES USEFUL AS PLASMA KALLIKREIN INHIBITOR | 2014 |
|
RU2712621C2 |
| PEPTIDILE HETEROCYCLES USED TO TREAT THROMBIN- ASSOCIATED DISEASES | 1996 |
|
RU2181125C2 |
| PYRAZOL DERIVATIVES, MEDICAL COMPOSITIONS, CONTAINING THEM, THEIR APPLICATION IN MEDICINE AND INTERMEDIATE COMPOUNDS FOR THEIR PRODUCTION | 2003 |
|
RU2369613C2 |
| AMINO ACID DERIVATIVES | 1994 |
|
RU2127261C1 |
| DERIVATIVES OF SPIRO-[ISOQUINOLINE-4-(1H)-3-PYRROLIDINE]-1,2',3,5'-(2H)-TETR- -ONE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION USED FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS-RELATED COMPLICATIONS | 1991 |
|
RU2110518C1 |
| COMPOSITIONS AND METHODS FOR TREATMENT OF BRAIN DAMAGE | 2018 |
|
RU2797548C2 |
| BICYCLIC DIHYDROPYRIMIDINECARBOXAMIDE DERIVATIVES AS RHO-KINASE INHIBITORS | 2017 |
|
RU2778478C2 |
| SUBSTITUTED DERIVATIVES OF BENZENE OR THEIR SALTS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2276137C2 |
